+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Plasma Fractionation - Global Market Trajectory & Analytics

  • ID: 4805742
  • Report
  • May 2020
  • Region: Global
  • 188 pages
  • Global Industry Analysts, Inc
1 of 2
Amid the COVID-19 crisis and the looming economic recession, the Plasma Fractionation market worldwide will grow by a projected US$9.8 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 5.4%. Intravenous Immunoglobulins, one of the segments analyzed and sized in this study, is forecast to grow at over 5.8% and reach a market size of US$10.9 Billion by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Intravenous Immunoglobulins market will be reset to a new normal which going forward in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 6.4% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$449.5 Million to the region's size over the next 7 to 8 years. In addition, over US$440.8 Million worth of projected demand in the region will come from Rest of the European markets. In Japan, the Intravenous Immunoglobulins segment will reach a market size of US$922.9 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Plasma Fractionation market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world’s second largest economy will grow at 5.7% over the next couple of years and add approximately US$1.7 Billion in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Plasma Fractionation market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others:

Bio Products Laboratory Ltd, Biotest AG, China Biologic Products, Inc, CSL Limited, Green Cross Corporation, Grifols SA, Japan Blood Products Organization, Kedrion SpA, LFB SA, Octapharma AG, Sanquin, Shanghai RAAS Blood Products Co, Ltd, Shire PLC

The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.
Note: Product cover images may vary from those shown
2 of 2
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Plasma Fractionation Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Plasma Fractionation Global Market Estimates and Forecasts in US$ Millionby Region/Country: 2020-2027
TABLE 2: Plasma Fractionation Global Retrospective Market Scenario in US$ Millionby Region/Country: 2012-2019
TABLE 3: Plasma Fractionation Market Share Shift across Key Geographies Worldwide:2012 VS 2020 VS 2027
TABLE 4: Intravenous Immunoglobulins (Product) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 5: Intravenous Immunoglobulins (Product) Historic Market Analysis by Region/Countryin US$ Million: 2012 to 2019
TABLE 6: Intravenous Immunoglobulins (Product) Market Share Breakdown of Worldwide Salesby Region/Country: 2012 VS 2020 VS 2027
TABLE 7: Coagulation Factor Concentrates (Product) Potential Growth Markets Worldwidein US$ Million: 2020 to 2027
TABLE 8: Coagulation Factor Concentrates (Product) Historic Market Perspective by Region/Countryin US$ Million: 2012 to 2019
TABLE 9: Coagulation Factor Concentrates (Product) Market Sales Breakdown by Region/Countryin Percentage: 2012 VS 2020 VS 2027
TABLE 10: Albumin (Product) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
TABLE 11: Albumin (Product) Region Wise Breakdown of Global Historic Demand in US$ Million:2012 to 2019
TABLE 12: Albumin (Product) Market Share Distribution in Percentage by Region/Country:2012 VS 2020 VS 2027
TABLE 13: Protease Inhibitors (Product) World Market Estimates and Forecasts by Region/Countryin US$ Million: 2020 to 2027
TABLE 14: Protease Inhibitors (Product) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
TABLE 15: Protease Inhibitors (Product) Market Share Breakdown by Region/Country:2012 VS 2020 VS 2027
TABLE 16: Other Products (Product) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 17: Other Products (Product) Historic Market Analysis by Region/Country in US$ Million:2012 to 2019
TABLE 18: Other Products (Product) Market Share Distribution in Percentage by Region/Country:2012 VS 2020 VS 2027
TABLE 19: Hospitals & Clinics (End-Use) Sales Estimates and Forecasts in US$ Millionby Region/Country for the Years 2020 through 2027
TABLE 20: Hospitals & Clinics (End-Use) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019
TABLE 21: Hospitals & Clinics (End-Use) Global Market Share Distribution by Region/Countryfor 2012, 2020, and 2027
TABLE 22: Clinical Research Laboratories (End-Use) Global Opportunity Assessment in US$ Millionby Region/Country: 2020-2027
TABLE 23: Clinical Research Laboratories (End-Use) Historic Sales Analysis in US$ Millionby Region/Country: 2012-2019
TABLE 24: Clinical Research Laboratories (End-Use) Percentage Share Breakdown of Global Salesby Region/Country: 2012 VS 2020 VS 2027
TABLE 25: Academic Institutes (End-Use) Worldwide Sales in US$ Million by Region/Country:2020-2027
TABLE 26: Academic Institutes (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019
TABLE 27: Academic Institutes (End-Use) Market Share Shift across Key Geographies:2012 VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Plasma Fractionation Market Share (in %) by Company: 2019 & 2025
Market Analytics
TABLE 28: United States Plasma Fractionation Market Estimates and Projections in US$ Million by Product: 2020 to 2027
TABLE 29: Plasma Fractionation Market in the United States by Product: A Historic Reviewin US$ Million for 2012-2019
TABLE 30: United States Plasma Fractionation Market Share Breakdown by Product:2012 VS 2020 VS 2027
TABLE 31: United States Plasma Fractionation Latent Demand Forecasts in US$ Millionby End-Use: 2020 to 2027
TABLE 32: Plasma Fractionation Historic Demand Patterns in the United States by End-Usein US$ Million for 2012-2019
TABLE 33: Plasma Fractionation Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027
CANADA
TABLE 34: Canadian Plasma Fractionation Market Estimates and Forecasts in US$ Millionby Product: 2020 to 2027
TABLE 35: Canadian Plasma Fractionation Historic Market Review by Product in US$ Million:2012-2019
TABLE 36: Plasma Fractionation Market in Canada: Percentage Share Breakdown of Salesby Product for 2012, 2020, and 2027
TABLE 37: Canadian Plasma Fractionation Market Quantitative Demand Analysis in US$ Millionby End-Use: 2020 to 2027
TABLE 38: Plasma Fractionation Market in Canada: Summarization of Historic Demand Patternsin US$ Million by End-Use for 2012-2019
TABLE 39: Canadian Plasma Fractionation Market Share Analysis by End-Use:2012 VS 2020 VS 2027
JAPAN
TABLE 40: Japanese Market for Plasma Fractionation: Annual Sales Estimates and Projectionsin US$ Million by Product for the Period 2020-2027
TABLE 41: Plasma Fractionation Market in Japan: Historic Sales Analysis in US$ Millionby Product for the Period 2012-2019
TABLE 42: Japanese Plasma Fractionation Market Share Analysis by Product:2012 VS 2020 VS 2027
TABLE 43: Japanese Demand Estimates and Forecasts for Plasma Fractionation in US$ Millionby End-Use: 2020 to 2027
TABLE 44: Japanese Plasma Fractionation Market in US$ Million by End-Use: 2012-2019
TABLE 45: Plasma Fractionation Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027
CHINA
TABLE 46: Chinese Plasma Fractionation Market Growth Prospects in US$ Million by Productfor the Period 2020-2027
TABLE 47: Plasma Fractionation Historic Market Analysis in China in US$ Million by Product:2012-2019
TABLE 48: Chinese Plasma Fractionation Market by Product: Percentage Breakdown of Salesfor 2012, 2020, and 2027
TABLE 49: Chinese Demand for Plasma Fractionation in US$ Million by End-Use: 2020 to 2027
TABLE 50: Plasma Fractionation Market Review in China in US$ Million by End-Use: 2012-2019
TABLE 51: Chinese Plasma Fractionation Market Share Breakdown by End-Use:2012 VS 2020 VS 2027
EUROPE
Market Facts & Figures
European Plasma Fractionation Market: Competitor Market Share Scenario (in %)for 2019 & 2025
Market Analytics
TABLE 52: European Plasma Fractionation Market Demand Scenario in US$ Millionby Region/Country: 2020-2027
TABLE 53: Plasma Fractionation Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
TABLE 54: European Plasma Fractionation Market Share Shift by Region/Country:2012 VS 2020 VS 2027
TABLE 55: European Plasma Fractionation Market Estimates and Forecasts in US$ Millionby Product: 2020-2027
TABLE 56: Plasma Fractionation Market in Europe in US$ Million by Product: A HistoricReview for the Period 2012-2019
TABLE 57: European Plasma Fractionation Market Share Breakdown by Product:2012 VS 2020 VS 2027
TABLE 58: European Plasma Fractionation Addressable Market Opportunity in US$ Millionby End-Use: 2020-2027
TABLE 59: Plasma Fractionation Market in Europe: Summarization of Historic Demandin US$ Million by End-Use for the Period 2012-2019
TABLE 60: European Plasma Fractionation Market Share Analysis by End-Use:2012 VS 2020 VS 2027
FRANCE
TABLE 61: Plasma Fractionation Market in France by Product: Estimates and Projectionsin US$ Million for the Period 2020-2027
TABLE 62: French Plasma Fractionation Historic Market Scenario in US$ Million by Product:2012-2019
TABLE 63: French Plasma Fractionation Market Share Analysis by Product: 2012 VS 2020 VS 2027
TABLE 64: Plasma Fractionation Quantitative Demand Analysis in France in US$ Millionby End-Use: 2020-2027
TABLE 65: French Plasma Fractionation Historic Market Review in US$ Million by End-Use:2012-2019
TABLE 66: French Plasma Fractionation Market Share Analysis: A 17-Year Perspectiveby End-Use for 2012, 2020, and 2027
GERMANY
TABLE 67: Plasma Fractionation Market in Germany: Recent Past, Current and Future Analysisin US$ Million by Product for the Period 2020-2027
TABLE 68: German Plasma Fractionation Historic Market Analysis in US$ Million by Product:2012-2019
TABLE 69: German Plasma Fractionation Market Share Breakdown by Product:2012 VS 2020 VS 2027
TABLE 70: Plasma Fractionation Market in Germany: Annual Sales Estimates and Forecastsin US$ Million by End-Use for the Period 2020-2027
TABLE 71: German Plasma Fractionation Market in Retrospect in US$ Million by End-Use:2012-2019
TABLE 72: Plasma Fractionation Market Share Distribution in Germany by End-Use:2012 VS 2020 VS 2027
ITALY
TABLE 73: Italian Plasma Fractionation Market Growth Prospects in US$ Million by Productfor the Period 2020-2027
TABLE 74: Plasma Fractionation Historic Market Analysis in Italy in US$ Million by Product:2012-2019
TABLE 75: Italian Plasma Fractionation Market by Product: Percentage Breakdownof Sales for 2012, 2020, and 2027
TABLE 76: Italian Demand for Plasma Fractionation in US$ Million by End-Use: 2020 to 2027
TABLE 77: Plasma Fractionation Market Review in Italy in US$ Million by End-Use: 2012-2019
TABLE 78: Italian Plasma Fractionation Market Share Breakdown by End-Use:2012 VS 2020 VS 2027
UNITED KINGDOM
TABLE 79: United Kingdom Market for Plasma Fractionation: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2020-2027
TABLE 80: Plasma Fractionation Market in the United Kingdom: Historic Sales Analysisin US$ Million by Product for the Period 2012-2019
TABLE 81: United Kingdom Plasma Fractionation Market Share Analysis by Product:2012 VS 2020 VS 2027
TABLE 82: United Kingdom Demand Estimates and Forecasts for Plasma Fractionationin US$ Million by End-Use: 2020 to 2027
TABLE 83: United Kingdom Plasma Fractionation Market in US$ Million by End-Use: 2012-2019
TABLE 84: Plasma Fractionation Market Share Shift in the United Kingdom by End-Use:2012 VS 2020 VS 2027
REST OF EUROPE
TABLE 85: Rest of Europe Plasma Fractionation Market Estimates and Forecasts in US$ Millionby Product: 2020-2027
TABLE 86: Plasma Fractionation Market in Rest of Europe in US$ Million by Product: A Historic Review for the Period 2012-2019
TABLE 87: Rest of Europe Plasma Fractionation Market Share Breakdown by Product:2012 VS 2020 VS 2027
TABLE 88: Rest of Europe Plasma Fractionation Addressable Market Opportunity in US$ Millionby End-Use: 2020-2027
TABLE 89: Plasma Fractionation Market in Rest of Europe: Summarization of Historic Demandin US$ Million by End-Use for the Period 2012-2019
TABLE 90: Rest of Europe Plasma Fractionation Market Share Analysis by End-Use:2012 VS 2020 VS 2027
ASIA-PACIFIC
TABLE 91: Plasma Fractionation Market in Asia-Pacific by Product: Estimates and Projectionsin US$ Million for the Period 2020-2027
TABLE 92: Asia-Pacific Plasma Fractionation Historic Market Scenario in US$ Millionby Product: 2012-2019
TABLE 93: Asia-Pacific Plasma Fractionation Market Share Analysis by Product:2012 VS 2020 VS 2027
TABLE 94: Plasma Fractionation Quantitative Demand Analysis in Asia-Pacific in US$ Millionby End-Use: 2020-2027
TABLE 95: Asia-Pacific Plasma Fractionation Historic Market Review in US$ Millionby End-Use: 2012-2019
TABLE 96: Asia-Pacific Plasma Fractionation Market Share Analysis: A 17-Year Perspectiveby End-Use for 2012, 2020, and 2027
REST OF WORLD
TABLE 97: Rest of World Plasma Fractionation Market Estimates and Forecasts in US$ Millionby Product: 2020 to 2027
TABLE 98: Rest of World Plasma Fractionation Historic Market Review by Product in US$ Million: 2012-2019
TABLE 99: Plasma Fractionation Market in Rest of World: Percentage Share Breakdownof Sales by Product for 2012, 2020, and 2027
TABLE 100: Rest of World Plasma Fractionation Market Quantitative Demand Analysisin US$ Million by End-Use: 2020 to 2027
TABLE 101: Plasma Fractionation Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
TABLE 102: Rest of World Plasma Fractionation Market Share Analysis by End-Use:2012 VS 2020 VS 2027

IV. COMPETITION
Total Companies Profiled: 47
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll